Full-Time

Data Operations Specialist

Confirmed live in the last 24 hours

Agilent Technologies

Agilent Technologies

10,001+ employees

eProcurement solutions for streamlined purchasing

No salary listed

Mid

Bawal, India

In Person

Category
Generalist Operations
Quality Control & Compliance
Operations & Logistics
Required Skills
SAP Products
Requirements
  • Critical thinker, good analytical skills, Strong customer-focus & Data-driven approach.
  • Problem-solving & decision-making abilities to support the internal partner in order to achieve their goals.
  • Hands on experience in SAP CRM, Mendix Web tool, ECC T-codes, Google Geo-mapping search engine. Technical MS Office knowledge is additional advantage.
  • Excellent verbal/written communication skills, as would need to engage with internal partners to understand their requirement.
  • Experienced working in a multi-cultural, global environment.
  • Strong portfolio, excellent attitude and a good team player
  • Delivery oriented and able to work independently under strict deadlines. Knowledge of processes & documentation.
  • Experience - 3-5 years, preferred prior work experience in Operations & master data.
Responsibilities
  • Handling internal/ external customer operational request with quality in pre-defined timeline.
  • Communicating and coordinating with internal partner as necessary.
  • Transactions tickets processing while meeting strict TAT timelines.
  • Bring inconsistencies and problems to the attention of the management.
  • Work with other teams in coordination for customer data governance, master data management, banking information management, collaboration with credit evaluation, taxes and compliance.
  • Authorized for creation and maintenance of customer master data.
  • Able to adjust to rotational work environment and flexible in shift coverage.
  • Will be responsible for maintaining, enhancing, and enforcing the discipline required for maintaining integrity of the process.
Desired Qualifications
  • Technical MS Office knowledge is additional advantage.
  • Preferred prior work experience in Operations & master data.

Agilent Technologies provides electronic procurement services that help businesses streamline their purchasing processes. Their suite of eProcurement services allows clients to integrate their pricing into existing platforms, access a hosted catalog, and conduct transactions without paper. This system is designed to help businesses quickly find and purchase the products they need at the right price, enhancing productivity through automation and simplified workflows. Agilent stands out from competitors by focusing on reliability and quality, serving a diverse range of clients who benefit from their expertise. The company's goal is to lower costs and increase profitability for its clients by improving efficiency in procurement.

Company Size

10,001+

Company Stage

IPO

Headquarters

Santa Clara, California

Founded

1999

Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisitions like Sigsense enhance Agilent's AI capabilities in lab operations.
  • The trend towards paperless transactions boosts Agilent's service efficiency and appeal.
  • Automation in procurement is expected to increase, benefiting Agilent's offerings.

What critics are saying

  • Integration challenges from acquiring BIOVECTRA may disrupt Agilent's operations.
  • Multiple acquisitions could stretch Agilent's resources and management focus.
  • Increased competition from funded companies like RareCyte and Elegen may challenge Agilent.

What makes Agilent Technologies unique

  • Agilent offers a comprehensive suite of eProcurement services for streamlined purchasing.
  • The company focuses on automation and paperless transactions to enhance business productivity.
  • Agilent's hosted catalog and pricing integration simplify procurement processes for clients.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Performance Bonus

Stock Options

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

5%

2 year growth

5%
Business Wire
Jul 30th, 2024
Agilent Acquires Sigsense, Creator of AI-Enabled Lab Operations Technology

Agilent has acquired Sigsense Technologies, a startup that uses artificial intelligence and power monitoring to optimize lab operations.

Biovectra
Jul 22nd, 2024
Agilent Technologies to Acquire BIOVECTRA Inc., Creating New Synergistic Opportunities to Improve Patient Care | BIOVECTRA

CHARLOTTETOWN, Prince Edward Island and SANTA CLARA, California – July 22, 2024 BIOVECTRA Inc. and Agilent Technologies, Inc. (NYSE: A) today announced the signing of an agreement for Agilent to acquire BIOVECTRA, a Canadian-based Contract Development and Manufacturing Organization, from H.I.G. Capital for $925 million. The acquisition provides the ability to expand the range of [...]Read More...

Finsmes
Jun 27th, 2024
RareCyte Secures $20M Financing

RareCyte, a Seattle, WA-based Life Sciences company providing precision biology platforms including instruments, reagents, software, and services, raised $20M in funding

Business Wire
May 14th, 2024
Elegen Raises $35 Million In Series B To Accelerate Expansion Into Clinical Manufacturing

SAN CARLOS, Calif.--(BUSINESS WIRE)--Elegen, the leader in next-generation DNA synthesis and production, today announced a Series B financing of $35 million led by Triatomic Capital. Also joining the round are strategic investors GSK, which recently entered a collaboration and licensing agreement with Elegen to use their proprietary cell-free DNA manufacturing technology in developing GSK’s vaccines and medicines, and John Ballantyne, co-founder of Aldevron. Elegen’s current investors, including Andreessen Horowitz (a16z Bio + Health), KdT Ventures, 8VC, Digitalis Ventures, ACVC Partners, Alix Ventures, AME Cloud Ventures and Agilent Technologies, also participated. The new funds will accelerate the extension of the company’s rapidly growing ENFINIA™ DNA product line across clinical workflows providing turnkey production of GMP-compliant DNA for clinical development of genetic medicines. “The age of genetic medicines is here, but these powerful modalities require innovative new manufacturing approaches to supply the critical input DNA material for rapid discovery, development and then wide-scale production,” said Matthew Hill, Ph.D., Elegen Founder and CEO. “With this investment, we will continue to push the boundaries of DNA synthesis to accelerate upstream discovery and enable rapid and streamlined deployment of new clinical modalities.”

GenomeWeb
Apr 3rd, 2024
Biofidelity Raises $24M to Expand US Commercialization of Lung Cancer Test, Product Pipeline

The firm said it also plans to use the money, which brings its total raised to $60 million, to establish a dedicated manufacturing facility in the UK.